Tres-K Denmed Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 0.15 M
- Company Age 6 Year, 12 Days
- Last Filing with ROC 31 Mar 2022
- Open Charges ₹ 4.00 M
- Revenue Growth -45.58%
- Profit Growth 104.88%
- Ebitda 119.87%
- Net Worth
- Total Assets 33.13%
About Tres-K Denmed
Tres-K Denmed Private Limited (TDPL) is a Private Limited Indian Non-Government Company incorporated in India on 11 February 2019 (Six years 12 days old ). Its registered office is in Kanpur Nagar, Uttar Pradesh, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2022. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.15 M.
The company currently has active open charges totaling ₹4.00 M.
Mehar Sughra and Intikhab Husain serve as directors at the Company.
Company Details
- Location
Kanpur Nagar, Uttar Pradesh, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U74999UP2019PTC113510
- Company No.
113510
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
11 Feb 2019
- Date of AGM
30 Sep 2022
- Date of Balance Sheet
31 Mar 2022
- Listing Status
Unlisted
- ROC Code
Roc Kanpur
Industry
Who are the key members and board of directors at Tres-K Denmed?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Mehar Sughra  | Director | 11-Feb-2019 | Current |
| Intikhab Husain | Director | 12-Nov-2022 | Current |
Financial Performance of Tres-K Denmed.
Tres-K Denmed Private Limited, for the financial year ended 2021, experienced significant reduction in revenue, with a 45.58% decrease. The company also saw a substantial improvement in profitability, with a 104.88% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth | |||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Tres-K Denmed?
In 2021, Tres-K Denmed had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹4.00 M
₹0
Charges Breakdown by Lending Institutions
- Others : 0.40 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 06 Feb 2024 | Others | ₹4.00 M | Open |
How Many Employees Work at Tres-K Denmed?
Unlock and access historical data on people associated with Tres-K Denmed, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Tres-K Denmed, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Tres-K Denmed's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
